⌘+K

Company description

Medivir develops innovative therapies targeting areas of high unmet medical need. Its most advanced asset is fostroxacitabine bralpamide (fostrox), a novel treatment for patients with advanced hepatocellular carcinoma (HCC) whose tumours have progressed despite first-line (1L) therapy. In addition, the company is developing a cathepsin K inhibitor, MIV-711, as a potential treatment for osteogenesis imperfecta and Perthes disease. Beyond its internal programmes, Medivir has partnered assets with companies including, Biossil, Infex Therapeutics, and Vetbiolix.

Key industry drivers

  • Upcoming patent expiries on several high-selling drugs are expected to drive strong industry demand for new pipeline assets

  • Demand for new and more effective therapies

Industry outlook

  • A global ageing population supports growing underlying demand for pharmaceutical treatments

  • The global medicines market is projected to grow at a CAGR of 5–8% through 2030 (IQVIA).

  • Key peers

    We consider BioInvent, Cantargia, Egetis Therapeutics, Faron Pharmaceuticals and Vicore Pharma to be Medivir’s closest peers

    Shareholders

    Name

    Capital

    Votes

    Hallberg Management AB.

    16.0 %

    16.0 %

    Carl Bennet

    15.3 %

    15.4 %

    Linc

    12.0 %

    12.1 %

    Nordea Funds

    5.3 %

    5.4 %

    Claesson & Andrezen

    3.9 %

    3.9 %

    Avanza Pension

    3.3 %

    3.3 %

    About DNB Carnegie Access

    DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

    Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

    Private Banking

    Tailored wealth management. Your financial future, personalized.

    Montrose

    A digital investment platform designed for passionate investors.

    DNB Carnegie

    Leading Nordic investment bank and wealth management.

    © Copyright DNB Carnegie Investment Bank AB